Elafibranor for primary biliary cholangitis at ALP below 1.67 × ULN: Progress toward a goal, no evidence yet of arrival.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.